Advanced Medical : Notice of Annual General Meeting and Annual Report

30 April 2019

Advanced Medical Solutions Group plc

('AMS', the 'Company'or the 'Group')

Annual Report and Accounts for the year ended

31 December 2018 and Notice of AGM

Winsford, UK:Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, is pleased to announce thatin accordance with AIM Rules 20 and 26, the Annual Report and Financial Statements for the year ended 31 December 2018 were posted to shareholders today and are available on the Investor Relations section of the Company's websitehttp://www.admedsol.com/Investor-Relations.

The notice of meeting convening the Annual General Meeting of the Company, which will be held on 5 June 2019 at 11 a.m. at the Guildhall Room, 85 Gresham Street, London, EC2V 7NQ, was also posted to shareholders today and is available on the Company's website.

- Ends -

For further information, please visitwww.admedsol.comor contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Daniel Adams / Patrick Robb / Gary Clarence

About Advanced Medical Solutions Group plc - seewww.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include tissue adhesives, sutures, biosurgical devices, internal sealants, silver alginates, alginates and foams, which it markets under its brands; LiquiBand®, LiquiBand® Fix 8™, RESORBA® and ActivHeal® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 630 employees. For more information, please seewww.admedsol.com.